SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...

Death of the 20-minute Rule
News | 11. 01. 2009
Venture capitalists have always preferred their backyards. This preference is captured in the so-called "20-minute rule," which describes an investor's tendency to invest in companies located within a 20-minute drive of the fund's office.